CPHI

China Pharma (CPHI)

China Pharma Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CPHI

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	05:06	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CPHI	China Pharma Holdings Inc
2024/05/09	05:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2024/02/24	06:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2024/02/24	06:05	PR Newswire (US)	China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split	AMEX:CPHI	China Pharma Holdings Inc
2024/02/15	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	AMEX:CPHI	China Pharma Holdings Inc
2024/02/09	06:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2024/02/07	06:16	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	AMEX:CPHI	China Pharma Holdings Inc
2024/01/27	07:04	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	AMEX:CPHI	China Pharma Holdings Inc
2024/01/27	07:04	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	AMEX:CPHI	China Pharma Holdings Inc
2024/01/13	06:05	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	AMEX:CPHI	China Pharma Holdings Inc
2024/01/13	04:42	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	AMEX:CPHI	China Pharma Holdings Inc
2023/12/22	06:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2023/12/20	06:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2023/11/29	22:00	PR Newswire (US)	China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device	AMEX:CPHI	China Pharma Holdings Inc
2023/11/14	06:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CPHI	China Pharma Holdings Inc
2023/11/08	06:05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:CPHI	China Pharma Holdings Inc
2023/10/28	05:06	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	AMEX:CPHI	China Pharma Holdings Inc
2023/10/20	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CPHI	China Pharma Holdings Inc
2023/10/04	05:05	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CPHI	China Pharma Holdings Inc
2023/08/15	04:40	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CPHI	China Pharma Holdings Inc
2023/08/09	21:30	PR Newswire (US)	China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs	AMEX:CPHI	China Pharma Holdings Inc
2023/05/13	05:07	Edgar (US Regulatory)	Quarterly Report (10-q)	AMEX:CPHI	China Pharma Holdings Inc
2023/03/31	05:56	Edgar (US Regulatory)	Annual Report (10-k)	AMEX:CPHI	China Pharma Holdings Inc
2023/03/30	05:06	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:CPHI	China Pharma Holdings Inc
2023/03/10	06:07	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	AMEX:CPHI	China Pharma Holdings Inc
2023/03/10	06:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	AMEX:CPHI	China Pharma Holdings Inc
2023/02/25	06:07	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:CPHI	China Pharma Holdings Inc
2023/02/25	06:05	PR Newswire (US)	China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split	AMEX:CPHI	China Pharma Holdings Inc
2022/12/31	06:06	Edgar (US Regulatory)	Current Report Filing (8-k)	AMEX:CPHI	China Pharma Holdings Inc
2022/12/28	22:00	PR Newswire (US)	China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask	AMEX:CPHI	China Pharma Holdings Inc